Lyra therapeutics announces four abstracts selected for presentations at upcoming ers and ars meetings, including new lantern 6-month follow-up and pharmacokinetic data

Lyr-210 pharmacokinetic study chosen as a top clinical abstract at ars lyr-210 pharmacokinetic study chosen as a top clinical abstract at ars

LYRA Ratings Summary

LYRA Quant Ranking